Non-competitive antagonists of NMDA and AMPA receptors decrease seizure-induced c-fos protein expression in the cerebellum and protect against seizure symptoms in adult rats by Tóth, Zoltán et al.
Contents lists available at ScienceDirect
Acta Histochemica
journal homepage: www.elsevier.com/locate/acthis
Non-competitive antagonists of NMDA and AMPA receptors decrease
seizure-induced c-fos protein expression in the cerebellum and protect
against seizure symptoms in adult rats
Zoltán Tóth, András Mihály⁎, Adrienne Mátyás, Beáta Krisztin-Péva
Department of Anatomy, Faculty of Medicine, University of Szeged, Szeged, Hungary







A B S T R A C T
The aim of the present study was to examine the role of ionotropic glutamate receptors in the cerebellum during
generalized seizures. Epileptic neuronal activation was evaluated through the immunohistochemical detection of c-
fos protein in the cerebellar cortex. Generalized seizures were precipitated by the intraperitoneal injection of 4-
aminopyridine. The animals were pretreated with the NMDA receptor antagonists MK-801 (2mg/kg), amantadine
(50mg/kg), and the AMPA receptor antagonist GYKI 52466 hydrochloride (50mg/kg). Two hours after 4-ami-
nopyridine injection, the number of c-fos immunostained cell nuclei was counted in serial immunohistochemical
sections of the cerebellar vermis. The number of c-fos immunostained cell nuclei in the granular layer decreased
signiﬁcantly in animals pretreated with the glutamate receptor antagonists compared to the untreated animals
having convulsion. We can conclude that mossy ﬁber stimulation exerts its seizure-generating action mainly
through the ionotropic glutamate receptors of the mossy ﬁber synapses. Both NMDA and AMPA receptor an-
tagonists are eﬀective in reducing glutamate-mediated postsynaptic eﬀects in the cerebellar cortex.
1. Introduction
Epilepsy causes distinct neuropathological alterations in the cere-
bellum resulting in the signiﬁcant loss of Purkinje cells (Honavar and
Meldrum, 2002). Nevertheless, there are epileptic seizures which
clearly originate from pathological lesions of the cerebellum (Boop
et al., 2013). Moreover, stimulation of the cerebellum is used to treat
intractable epilepsy (Ge et al., 2013). The double-faced role of the
cerebellum in epilepsy can be explained by the double-faced anatomical
connections of the cerebellum and the neocortex-diencephalon axis.
The neocortex is projecting to the pontine nuclei, which project to the
cerebellum through the pontocerebellar tract (Lee and Mihailoﬀ, 1990).
Axon terminals of the corticopontine tract make excitatory synaptic
contacts with the dendrites of the pontine neurons (Brodal and Bjaalie,
1992). The glutamatergic pontocerebellar system terminates as mossy
ﬁbers in the granular layer of the cerebellar cortex stimulating mainly
granule cells and Golgi cells (Castejon and Castejon, 2000). The cere-
bellar eﬀerent information ﬂows to the deep cerebellar dentate nucleus,
which projects to the thalamus, and the thalamic neurons project to the
frontal neocortical areas in order to form excitatory synapses
(Geminiani et al., 2017). The dentate nucleus is also connected to the
pontine nuclei (Lee and Mihailoﬀ, 1990).
In our previous studies, we proved that generalized tonic–clonic
seizures (GTCS) precipitated by the potassium channel blocker 4-ami-
nopyridine (4-AP) caused long-lasting, signiﬁcant increase of c-fos
protein expression in the granular layer of the cerebellar cortex (Tóth
et al., 2015), very similarly to that seen in the hippocampus and neo-
cortex during seizure (Mihály et al., 2001; 2005). We also demonstrated
through immunohistochemistry and Western blotting methods that the
transection of the middle cerebellar peduncle (MCP) signiﬁcantly de-
creased c-fos expression in the animals with seizure (Tóth et al., 2015).
These ﬁndings suggested the primary importance of the mossy ﬁbers in
cerebellar seizure initiation (Tóth et al., 2015). Mossy ﬁbers of the MCP
use glutamate as a neurotransmitter (Somogyi et al., 1986). Accord-
ingly, granule cells in the cerebellar cortex have NMDA and AMPA type
ionotropic glutamate receptors (Limatola, 2003; Sanchez-Perez et al.,
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2005; Koutsouraki et al., 2013). Both NMDA and AMPA receptors are
able to induce the expression of transcription factors through strong
Ca++ inﬂux (Rogawski, 2013; Rothan et al., 2017). This ionotropic
glutamate transmission mechanism explains our observations of the
signiﬁcant increase in c-fos protein in the cerebellar cortex in 4-AP
seizures (Tóth et al., 2015). The pivotal role of the mossy ﬁbers in this
transcription factor expression has been proven through the transection
of the MCP, which reduced the ipsilateral c-fos expression by 80% (Tóth
et al., 2015). MCP transection has also aﬀected the contralateral cere-
bellar hemisphere, and the seizure-generated c-fos expression has de-
creased by 30% in the contralateral hemisphere, as detected by Western
blotting and immunohistochemistry (Tóth et al., 2015).
Ionotropic NMDA type glutamate receptor antagonist MK-801 (di-
zocilpine) is a selective, non-competitive antagonist, which has antic-
onvulsant and neuroprotective eﬀects as well (Wong et al., 1986;
Braitman and Sparenborg, 1989; Szakács et al., 2003). The low-aﬃnity
NMDA receptor blocker amantadine (1-aminoadamantane) has antic-
onvulsant and neuroprotective roles as well (Kornhuber et al., 1994;
Szakács et al., 2003). GYKI 52466 (1-(4-aminophenyl)-4-methyl-7,8-
methylenedioxy-5H-2,3-benzodiazepine hydrochloride) is a selective,
non-competitive antagonist of the AMPA-type glutamate receptors
(Donevan and Rogawski, 1993; Arai, 2001; Weiczner et al., 2008).
Previous experiments performed in our laboratory proved that seizure-
induced c-fos protein expression in the neocortex and hippocampus
could be signiﬁcantly inhibited by MK-801, amantadine, and GYKI
52466 pretreatments (Szakács et al., 2003; Weiczner et al., 2008).
Closer investigation of the diﬀerent receptor blockers revealed diﬀerent
action mechanisms in case of the NMDA (Zádor et al., 2008) and AMPA
receptor antagonists (Weiczner et al., 2008). The aim of the present
study was to measure the net changes in c-fos expression of cerebellar
granule cells in the 4-AP acute seizure model following pretreatment
with MK-801, amantadine, and GYKI 52466, and to compare their ef-
fectiveness on local neuronal activation (c-fos expression) and on the
complex behavioral symptoms of the 4-AP seizures.
2. Material and methods
Adult, male, 220–240 g (12–14-week old) Wistar rats were housed
in a light and a temperature-controlled room and had free access to
food and water. The animals were kept and the experiments were
conducted in accordance with prevailing laws and ethical considera-
tions of the European Union (European Community Council Directive;
2010/63/EU). Written permission for the protocols of the experiments
was obtained from the Ethics Committee for the Protection of Animals
in Research of the University of Szeged. Control, untreated animals (4
rats) received 1ml physiological saline intraperitoneally. The seizures
were induced with a single intraperitoneal (i.p.) injection of 4-amino-
pyridine (4-AP; Sigma-Aldrich, St. Louis, MO, USA) dissolved in phy-
siological saline (5mg/kg 4-AP, 0.67 mg/ml 4-AP concentration). In
previous investigations, this dose proved to be epileptogenic (Mihály
et al., 1990, 2001,2005; Tóth et al., 2015). The rats treated with 4-AP
displayed GTCS (ly et al., 1990, 2001;). The NMDA receptor antagonists
MK-801 and amantadine (Sigma, St. Louis, MO) were dissolved in
physiological saline. The GYKI 52466 hydrochloride (Sigma, St. Louis,
MO) was dissolved in 50% DMSO (DMSO: dimethyl sulfoxide; Sigma,
St. Louis, MO; de Sarro et al., 1995; Weiczner et al., 2008) in physio-
logical saline. The 4-AP-treated animals were divided into six groups
with four animals in each group (altogether 24 animals). In the ﬁrst set
of three groups, the animals were pretreated with glutamate receptor
antagonists MK-801 (2mg/kg), amantadine (50mg/kg), and GYKI
52466 hydrochloride (50mg/kg). After the pretreatment (15min fol-
lowing the administration of the antagonist), the convulsant 4-AP was
administered intraperitoneally (dose: 5 mg/kg). In the second set of
three groups, the animals received the solvent of the antagonists, and
15min later, the 4-AP. The experiments were ﬁnished 2 h after the 4-AP
injection. The symptoms during seizure were observed, and the latency
of the ﬁrst GTCS was measured. At the end of the observation (2 h
following the 4-AP injection), the rats were deeply anesthetized with
diethyl-ether (Fluka). The chest was opened, the aorta was cannulated,
and the animals were perfused with ﬁxative, which contained 4%
paraformaldehyde in 0.1 M phosphate buﬀer (pH 7.4). After the
transcardiac perfusion, the brain was dissected and postﬁxed in the
same ﬁxative for 1 h at room temperature. The vermis was separated
and soaked in 20% sucrose solution (20% sucrose in 0.1 phosphate
buﬀer, pH 7.4.) for 10–12 h. Sagittal plane frozen sections (24 μm
thickness) were cut on a freezing microtome and used as free-ﬂoating
sections in immunohistochemistry.
2.1. Behavioral studies
Ten adult male Wistar rats were used in every group (40 animals;
each 230 g, 13 weeks old). The NMDA receptor antagonists MK-801 and
amantadine (Sigma, St. Louis, MO) were dissolved in saline, whereas
GYKI 52466 hydrochloride (Sigma, St. Louis, MO) was dissolved in 50%
DMSO in saline (de Sarro et al., 1995; Weiczner et al., 2008). The sei-
zures were induced with a single i.p. injection of 4-AP, which was
dissolved in physiological saline (5 mg/kg 4-AP in 0.67 mg/mL ve-
hicle), and this 4-AP dose proved to be epileptogenic (ly et al., 1990,
2001; ; Tóth et al., 2015). The animals were pretreated with glutamate
receptor antagonists MK-801 (2mg/kg), amantadine (50mg/kg), and
GYKI 52466 (50mg/kg) via i.p. injection. After the pretreatment
(15min later), the convulsant agent 4-AP was administered i.p. (5 mg/
kg). In the control group, the animals received the solvent of the an-
tagonists (50% DMSO in 0.9% NaCl solution) and the 4-AP, and the
seizure symptoms were registered: the latency of the ﬁrst GTCS was
measured from the time of the 4-AP injection. The appearance of the
ﬁrst GTCS and the number of the animals which displayed the GTCS
were assessed (Table 1). The latencies of the ﬁrst GTCS were statisti-
cally investigated with one-way analysis of variance (ANOVA), whereas
the incidence of the generalized tonic–clonic seizure was analyzed by
Fisher's exact test using SPSS 9.0 statistical software. During the ana-
lysis, the pretreated groups were compared to the control group (4-AP
injected only), and the signiﬁcance level was p < 0.05. These animals
survived the experiments: the seizures symptoms decreased gradually,
and the animals recovered.
2.2. Immunohistochemistry
Polyclonal c-fos antibody (#sc-52, raised in rabbit; Santa Cruz
Biotechnology, Santa Cruz, CA, USA) and the peroxidase–antiperox-
idase (PAP) method were used. The speciﬁcity of the primary antibody
(#sc-52) was tested in our previous experiments with Western blotting
(Tóth et al., 2015). The sections were pretreated with 1.5% H2O2 and
rinsed in 0.1M phosphate-buﬀered saline (PBS). Then, they were in-
cubated in 20% normal pig serum, next, in primary c-fos antibody
(1:1000 in 20% normal pig serum in PBS and 0.2% sodium azide), and
then in donkey anti-rabbit IgG (1:40; Jackson Immuno-Research, West
Grove, PA, USA). The secondary antibody was detected with the PAP
technique (PAP complex diluted to 1:1000; Jackson Immuno-Research,
West Grove, PA, USA). The peroxidase reaction was localized with
diaminobenzidine tetrahydrochloride (DAB; Sigma-Aldrich), yielding a
brown reaction product. The sections were mounted on glass slides and
covered with Entellan® (Fluka).
2.3. Morphometric analysis of the immunohistochemical data
From every animal, ﬁve sagittal plane sections of the vermis were
selected. Areas of interest (AOIs) for counts of c-fos immunoreactive (c-
fosIR) neuronal nuclei were from every cerebellar lobule (I–X) from the
granule cell layer. The Purkinje-cell layer and the molecular layer were
not investigated. These layers will be analyzed in further studies.
Within each AOI, the c-fosIR cell nuclei were counted using a Nikon
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Eclipse 600 microscope equipped with a SPOT RT Slider digital camera
(1600×1200 dpi in 8 bits), with the help of Image Pro Plus 4.5 mor-
phometry software (Media Cybernetics, Bethesda, MD, USA). Following
background subtraction, the threshold was determined so that all la-
beled nuclei could be recognized. The counting was performed blindly
of the animals’ treatment. The AOI size was the rectangular image
capturing ﬁeld of the camera. Cells were counted using a 40× objec-
tive, and the AOI (1mm2) included a relatively large area of the
granular layer. We used the nomenclature of Voogd (2004) for the
identiﬁcation of the cerebellar lobules. The data from the animals in-
jected with 4-AP and the solvents of the antagonists were merged into
one set. This was possible, because the solvent was 0.9% NaCl. In the
case of GYKI 52466 the solvent was 50% DMSO in 0.9% NaCl. This
solvent did not interfere with the seizure process, and did not inﬂuence
the seizure-related c-fos staining (Weiczner et al., 2008). The data were
analyzed statistically comparing sets of measurements obtained with
the same magniﬁcation. The cell counts were normalized to 1mm2.
Diﬀerences in the number of c-fosIR cells in the control and in the
convulsing animals were analyzed with one-way analysis of variance
(ANOVA), followed by the Bonferroni post hoc test. The signiﬁcance
criterion was p < 0.05, and the statistical analysis was performed with
the SPSS 9.0 software (SPSS, IBM, Chicago, IL, USA).
3. Results
3.1. Behavioral analysis of the antagonistic eﬀects
The i.p. injection of 4-AP caused characteristic behavioral symptoms
(increased exploratory activity, muscle tremor, limb clonuses, and shi-
vering) within 15–20min, similarly to that previously described by
Mihály et al. (1990). At the peak of the shivering, the GTCS appeared
suddenly and unequivocally, so the latency of the onset of every GTCS
could be measured (Table 1). In the group treated with 4-AP, the average
latency of the GTCS was 32.2min. A quiet postictal period followed the
GTCS, and approximately 90min after the ﬁrst GTCS, total recovery was
seen. The latency of the GTCS increased signiﬁcantly only in animals that
were pretreated with MK-801 (Table 1). Amantadine and GYKI 52466
did not inﬂuence the latency of the GTCS signiﬁcantly (Table 1). How-
ever, the number of the animals displaying GTCS decreased in every
pretreated group; in the group pretreated with MK-801, only 80% of the
animals displayed GTCS, in the amantadine group, only 70% of the an-
imals displayed GTCS, and in the GYKI 52466 group, only 60% of the
animals displayed GTCS (Table 1). These variations of the animal num-
bers displaying GTCS were not signiﬁcant as investigated with the
Fisher’s test (Table 1). Animals without GTCS displayed only shivering,
minor limb clonuses, and increased exploratory activity. In the 4-AP
treated group, 100% of the animals displayed GTCS (Table 1).
3.2. Number of c-fos IR cells following pretreatment with glutamate receptor
antagonists
The c-fos immunostaining labeled the cell nuclei (Fig. 1). The mo-
lecular layer contained few c-fosIR cell nuclei (Fig. 1). Purkinje cells did
not contain c-fos staining but their large cell bodies were surrounded by
scattered c-fosIR nuclei (Fig. 1). Large numbers of labeled cell nuclei in
convulsing animals were detectable in the granular layer in every
vermal lobule (Fig. 1A). On the other hand, the granular layer displayed
clear-cut alterations following the antagonist treatments (Fig. 1B–D).
Therefore, the granular layer was investigated in the present cell
counting experiments. According to our previous investigations (Tóth
et al., 2015), the number of c-fosIR cell nuclei raised signiﬁcantly at
1.5 h and reached the maximum increase between 2–3 h following the
administration of 4-AP (Tóth et al., 2015). Therefore, the 2 h survival
time was chosen for counting in the present experiments. The sum-
mated counts of the entire vermis displayed signiﬁcant diﬀerences:
while the controls injected with 0.9% NaCl solution displayed
559 ± 36 (S.E.M) c-fosIR nuclei in 1mm2 of the granular layer, the 4-
AP injected animals displayed 6202 ± 118 (S.E.M.) c-fosIR cell nuclei,
which is a highly signiﬁcant increase (p < 0.05). In comparison to the
eﬀects of 4-AP, there was a signiﬁcant decrease of the number of the c-
fosIR cell nuclei in the animals pretreated with the NMDA- and AMPA
receptor antagonists. In the GYKI 52466 treated animals the number of
c-fosIR nuclei was 4324 ± 87 (S.E.M.), in the MK-801 treated animals
the count was 3659 ± 92 (S.E.M.) and in the amantadine pretreated
rats the summated counts from the vermis showed 3853 ± 74 (S.E.M.)
c-fosIRcell nuclei in 1mm2 of the granular layer (p < 0.05 in every
pretreated animal in comparison to the 4-AP treated ones). C-fosIR cell
nuclei were also counted separately according to the vermal lobules
(Fig. 2). In the control animals (treated with physiological saline), the
number of the c-fosIR granule cells was very low (white columns in
Fig. 2). Following the 4-AP injections, large numbers of c-fos positive
cells were detected in every vermal lobule in the granular layer of the
cerebellar cortex (black columns in Fig. 2). This c-fosIR cell number is
signiﬁcantly higher than that in non-convulsing control animals in
every lobule (p < 0.05; Fig. 2). Pretreatment with GYKI 52466, MK-
801, and amantadine resulted in a signiﬁcant decrease in the number of
c-fosIR positive granule cells compared to the animals treated with the
solvents and 4-AP in every vermal lobule (Fig. 2). The antagonist-de-
pendent decrease of the c-fosIR granule cell numbers was signiﬁcant in
every vermal lobule (p < 0.01; Fig. 2).
4. Discussion
Previous research performed in our laboratory indicated that the 4-
AP model was reliable for the pharmacological investigation of seizure
genesis (Mihály et al., 1990; Szakács et al., 2003; Weiczner et al., 2008).
The careful counting of the Fos protein immunostained cell nuclei
served as a good indicator of seizure spread in the forebrain (Kovács
et al., 2003; Szakács et al., 2003) and cerebellar (Tóth et al., 2015)
structures, in vivo. Our previous studies proved that signiﬁcant seizure-
induced increases of the c-fos mRNA and c-fos protein were detectable
in the forebrain and in the cerebellum by polymerase chain reaction
and Western blotting, respectively (Szakács et al., 2003; Mihály et al.,
2005; Tóth et al., 2015).
4.1. c-Fos expression as a marker of neuronal activity
Our ﬁndings concerning the appearance of c-fos in the convulsing
brain are in accord with the data in the literature (Dragunow and
Robertson, 1987; Willoughby et al., 1997). The appearance of syn-
chronized population spikes was found to correlate well with c-fos
mRNA expression, which also correlated with presynaptic glutamate
release (Labiner et al., 1993). Therefore, the detection and evaluation of
c-fos immunoreactivity appears suitable for the histological mapping of
Table 1
Behavioral analysis of the experimental animals treated with 4-AP and receptor antago-
nists. The asterisk shows the signiﬁcant diﬀerence between latency times in the control
group (treated with 4-AP only) and the pretreated groups. In the control group GTCS oc-
cured in 100% of the animals. In case of the second group (pretreated with MK-801), the
GTCS latency was signiﬁcantly longer compared to the control animals (*p < 0.05). In this
group GTCS occured in 80% of the animals. In the other groups (pretreated with GYKI-
52466 and amantadine), there was no signiﬁcant diﬀerence in the latency time compared
to the control group. The appearance of generalized tonic–clonic seizure (animals dis-
playing GTCS) was analyzed by the Fisher's exact test using SPSS 9.0 statistical software. As







4-AP (control) 10 32,21 2,82 10/10
4-AP+MK 801 10 41,37* 4,94 8/10
4-AP+Amantadine 10 27,16 5,32 7/10
4-AP+GYKI 52466 10 39,56 4,57 6/10
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epileptic neuronal activity (Labiner et al., 1993; ly et al., 2001, 2005; ;
Tóth et al., 2015). Literature data (Herdegen and Leah, 1998; Labiner
et al., 1993) suggest that 4-AP induces c-fos expression in part through
the increased release of glutamate from the cerebellar synapses in vivo,
and in part through the concomitantly increased Ca2+ inﬂux into the
postsynaptic cells. Accordingly, decreased seizure-induced c-fos ex-
pression following the administration of NMDA- and AMPA antagonists
should indicate weakening of the postsynaptic eﬀects of glutamate and
the decrease of the concomitant inﬂux of Ca2+ in the postsynaptic
neuron (Greenberg and Ziﬀ, 2001).
4.2. Mechanism of seizure protection by non-competitive NMDA and AMPA
antagonists in the cerebellum
MK-801 and amantadine decrease the postsynaptic eﬀects of glu-
tamate mainly by blocking the NMDA receptor channel. The isotope-
labeled derivatives of these compounds are used in human brain ima-
ging studies to investigate the glutamate receptor function (Bressan and
Pilowsky, 2000). MK-801 is a high-aﬃnity open-channel blocker; it
blocks the ion channel of the receptor at the phencyclidine site and
inhibits or decreases the ion ﬂuxes, which follow the glutamate binding
(Chapman, 1998). Systemic and intracerebroventricular MK-801 ad-
ministration has been found to protect against 4-AP seizures in elec-
trophysiological experiments (Morales-Villagrán et al., 1996). The
present experiments provided further data on the protection against the
seizures, and they proved that MK-801 pretreatment inhibited GTCS
and reduced c-fos induction in the cerebellar cortex. Im-
munohistochemical studies have revealed the distribution of the NMDA
receptor subunits in the cerebellar cortex (Thompson et al., 2000).
Golgi cells express NR1 and NR2B, whereas granule cells are im-
munopositive for NR1, NR2A, NR2C and NR2D subunits (Thompson
et al., 2000). Purkinje cells display NR1, NR2B, NR2C/D im-
munoreactivity (Thompson et al., 2000). MK-801 inhibits eﬀectively
the receptors containing NR1/NR2A and NR1/NR2 B subunits (Paoletti
and Neyton, 2007), so it should be responsible for the large decrease in
the c-fosIR nuclei. On the other hand, MK-801 is the only antagonist
that increases GTCS latency signiﬁcantly; therefore, we think that the
granule cell NMDA receptors play an important role in the fast synaptic
transmission of the cerebellar mossy ﬁber synapses during seizures
(Delvendahl and Hallermann, 2016).
Amantadine is a low-aﬃnity open-channel antagonist (Parsons
et al., 1999). The family of aminoadamantanes displays anti-
parkinsonian-like activity as well as a neuroprotective action (Danysz
et al., 1997). We know that Ca2+ ﬂuxes are able to displace the an-
tagonist from the channel resulting in the cessation of its eﬀect (Parsons
et al., 1999) therefore, we can conclude that amantadine decreases the
Ca2+ inﬂux through the NMDA receptor transiently, and this may be
reﬂected in the decrease of the seizure-induced c-fos expression.
GYKI 52466 is a selective, non-competitive antagonist of the AMPA
receptor (Arai, 2001) with good blood–brain barrier permeability
(Barna et al., 2000). In our former studies, GYKI 52466 decreased c-fos
expression in the rat neocortex and hippocampus in 4-AP seizures
(Weiczner et al., 2008). The cerebellar granule cells possess AMPA re-
ceptors, the stimulation of which mediated calcium inﬂux into cultured
granule cells (Hack and Balázs, 1995). The calcium uptake in these
conditions has been successfully blocked by GYKI 52466 (Hack and
Fig. 1. Immunohistochemistry of c-fos pro-
tein localization in the cerebellar vermis 2 h
after 4-AP administration.
(A) The distribution of c-fos immunpositive
granule cell nuclei in the anterior lobe, lo-
bule III in the rat treated with 4-AP only.
(B) The distribution of c-fos immunpositive
granule cell nuclei in the anterior lobe, lo-
bule IV in the rat treated with GYKI 52466
and 4-AP.
(C) The distribution of c-fos immunpositive
granule cell nuclei in the posterior lobe, lo-
bule VII in the rat treated with MK-801 and
4-AP.
(D) The distribution of c-fos immunpositive
granule cell nuclei in the posterior lobe, lo-
bule VII in the rat treated with amantadine
and 4-AP.
Layers of the cerebellar cortex are indicated
(M: molecular layer, P: Purkinje cell layer,
GR: granular layer). The arrows show the
immunopositive cell nuclei in the granular
layer. The Purkinje cells are shown by as-
terisks. Scale bar: 100 μm.
Fig. 2. Quantitative assessment of c-fosIR cell nuclei numbers in
vermal lobules I–X, 2 h after 4-AP injection. Ordinate: number of cell
nuclei in 1mm2; abscissa: vermal lobules numbered from I to X. The c-
fosIR cells were counted in the granular layer of each cerebellar lo-
bule. Control animals treated with physiological saline displayed a
small number of c-fos-stained cell nuclei (white columns). Animals
treated with 4-AP displayed high numbers of c-fosIR cell nuclei (black
columns). Every antagonist pretreatment caused a signiﬁcant decrease
of c-fos expression compared to the 4-AP group. Four animals were
investigated in every group. Signiﬁcant diﬀerences compared to the 4-
AP treated values are shown by asterisks (*p < 0.05). The standard
error of the mean (SEM) is shown on the top of the columns.
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Balázs, 1995). The AMPA receptors of the granule cells are relatively
resistant to desensitization, and they support high-frequency synaptic
transmission in the mossy ﬁber glomerulus (Delvendahl and
Hallermann, 2016). We suppose that granule cell AMPA receptors were
successfully blocked in our GYKI 52466 pretreated animals, and the
blockade resulted in the signiﬁcant decrease of c-fos expression in the
granular layer. The solvent of GYKI 52466 (dimethyl sulfoxide) did not
exert any pharmacological eﬀect and did not inﬂuence the c-fos im-
munostaining (de Sarro et al., 1995; Weiczner et al., 2008).
4.3. The signiﬁcance of seizure antagonism in the cerebellum
The pharmacological antagonism of the NMDA and AMPA receptors
in the cerebellar cortex decreased the number of the c-fosIR cells sig-
niﬁcantly, similarly to that we detected in the contralateral hemisphere
after transection of the middle cerebellar peduncle (Tóth et al., 2015).
We conclude that these drugs can decrease the cerebellar activity
through postsynaptic mechanisms, acting at the dendrites of the
granule cells and decreasing their ﬁring upon the mossy ﬁber activity
(Delvendahl and Hallermann, 2016). The pharmacologically inhibited
ﬁring of the granule cells is reﬂected in the decrease of the postsynaptic
c-fos protein expression in the granular layer of the cerebellar cortex.
On the other hand, pharmacological action on the level of the pontine
nuclei is possible too, as the neurons of the pontocerebellar tract are
contacted by the corticopontine axon terminals, which also use gluta-
mate (Border and Mihailoﬀ, 1991). The postsynaptic membranes of
cerebellar neurons possess not only NMDA, but also AMPA and kainate
receptors. These ionotropic receptors respond to extracellular gluta-
mate: AMPA receptors trigger depolarization and burst initiation, and
then, NMDA receptors become activated, and the opening of the NMDA
channel generates large Ca2+ inﬂux (Hwa and Avoli, 1991; Löscher,
1998). The inﬂux of Ca2+ has an important role in the triggering of
neuronal damage (Chapman, 1998). It is important to note that MK-801
was not only inhibiting neuronal c-fos expression, but it also inhibited
the development of the seizure, as we measured signiﬁcantly longer
GTCS latencies in these animals. It may suggest that the blockade of the
NMDA channel by this non-competitive antagonist obviously inhibited
or delayed the postsynaptic inﬂux of Ca2+, which in turn should have
been delayed and inhibited the long lasting neuronal depolarization
(Hwa and Avoli, 1991), and it prevented seizure-related neuronal c-fos
expression and the behavioral symptoms as well.
It is important to highlight that GTCS, which represents the main
symptom of the 4-AP treatment, did not show strict correlation with the
inhibition of c-fos expression. Some animals pretreated with NMDA
antagonists and exhibiting decreased c-fos expression displayed GTCS;
nonetheless, the latency and the incidence of the symptoms were af-
fected signiﬁcantly. Inhibition of the NMDA receptor channel during
this period could inhibit the induction of the c-fos gene, whereas glu-
tamate release after this critical period may not induce further c-fos
expression, but it may cause the development of the symptoms and
maintain them. This could explain the discrepancy between the oc-
currence of GTCS and the decrease of c-fos immunoreactivity. Another
explanation could be based on the role of non-NMDA receptors in the
development and maintenance of the symptoms, as supported by the
literature data (Löscher, 1998).
5. Conclusions
1. The cerebellar cortex of the vermis is strongly activated in gen-
eralized 4-AP seizures.
2. The activation is primarily due to the stimulation of the pontocer-
ebellar mossy ﬁber pathway, and it can be monitored for 2 h by
means of the neuronal c-fos expression.
3. The mossy ﬁbers stimulate their postsynaptic targets through NMDA
and AMPA receptors, which mediate the long-lasting postsynaptic c-
fos expression.
4. The pharmacological blockade of these receptors attenuates the
seizure-related synaptic activation of the granule cell layer.
5. The antagonists of the NMDA and AMPA receptors could be useful in
the attenuation of the seizure-related neuronal damage in the cer-
ebellum.
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